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ORIGINAL ARTICLE
Impact of transient correction of increased 
adrenocortical activity in hypothalamo-damaged, 
hyperadipose female rats
G Moreno1, M Perello1, G Camihort2, G Luna2, G Console2, RC Gaillard3 and E Spinedi1
‘Neuroendocrine Unit, Multidisciplinary Institute on Cell Biology (CONICET-CICPBA), La Plata, Argentina; department of 
Histology and Embryology 'B', School of Medicine, UNLP-CICPBA, La Plata, Argentina and 3Division of Endocrinology, 
Diabetology & Metabolism, University Hospital (CHUV), Lausanne, Switzerland
Objective: To explore the effects of transient correction of enhanced corticoadrenal activity in monosodium L-glutamate (MSG)- 
damaged female rats on peripheral insulin sensitivity and in vitro retroperitoneal (RP) adipocyte function.
Designs: A dose of 4 mg/g body weight (BW) of MSG or vehicle (CTR) was i.p. injected, once every 2 days, between days 2 and 
10 of age, in female rats. Intact and 21 day-operated (sham or adrenal enucleation (AE)) rats from both (CTR and MSG) groups 
were used for experimentation on day 120 of age. Circulating levels of several hormones, in basal and after i.v. high-glucose load 
conditions, and RP adiposity morphology and function were then evaluated.
Results: MSG rats developed increased adrenocortical function, hyperadiposity, hyperleptinemia, hyperinsulinemia and 
decreased peripheral insulin sensitivity. These characteristics were fully reversed after transient correction of corticoadrenal 
hyperactivity induced by AE. In addition, in vitro experimentation with isolated RP adipocytes indicated that cells from intact 
MSG animals displayed decreased sensitivity to insulin and dexamethasone stimulation of leptin secretion. Interestingly, 
adipocyte dysfunction in MSG rats was fully abrogated after AE-induced transient correction of insulinemia, leptinemia and 
adrenocortical activity. Importantly, the reversion of these metabolic abnormalities, induced by AE for 21 days, in MSG animals 
did occur, despite no significant changes in BW values.
Conclusion: Our results support that the changes in adipocyte characteristics and peripheral insulin resistance, developed in this 
pseudo-obese female rat model, are mainly due to increased glucocorticoid production. Importantly, appropriate correction of 
the enhanced adrenocortical activity fully reversed these abnormal functions.
International Journal of Obesity (2006) 30, 73-82. doi:10.1038/sj.ijo.0803109; published online 11 October 2005
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Introduction
Hypothalamic lesions induced in rats is a widely recognized 
tool for studies of changes in neuroendocrine functions. 
Monosodium L-glutamate (MSG) administration in neonatal 
rats is recognized to mainly damage hypothalamic arcuate 
nucleus (ARC) neurons.1-3 MSG-induced partial hypothala­
mic denervation alters several neuroendocrine-metabolic 
functions. It has been proposed that early loss of hypo­
thalamic neurotransmitters induced by MSG, namely in the 
ARC,1,4,5 is responsible for such abnormalities. Among these, 
MSG animals develop a number of morphological, behavior-
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al, and endocrine abnormalities.2,3’4’6’7 Also, the changes in 
hypothalamic neuronal function particularly enhance hypo- 
thalamo-pituitary-adrenal (HPA) axis activity.'8 12 It is 
known that hypophagic,13 MSG-damaged rats are character­
ized by increased adiposity and insulin resistance;14 how­
ever, the exact mechanisms whereby these abnormalities 
develop are not fully understood.
These MSG-induced changes in HPA axis activity, a key 
function for maintaining homeostasis, have been attributed 
to dysfunctions of several hypothalamic peptidergic and 
monoaminergic systems18 17 driving pituitary function, and, 
in turn, modifying adrenal development and function,11 
thus resulting in enhanced corticoadrenal activity8 12 The 
bi-directional crosstalk between HPA axis and adipose tissue 
activities is widely accepted.18 We recently demonstrated 
that the peripheral satiety signal leptin,19 a physiological 
inhibitor of ACTH-driven adrenal glucocorticoid 
production,20 is several fold increased in the circulation of
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MSG rats shortly after the end of treatment, and is even more 
pronounced at adulthood.21 Interestingly, the mRNA expres­
sion of its biologically active receptor (Ob-Rb) is reduced in 
the adrenal gland of MSG rats.22 Thus, in this animal model, 
enhanced HPA axis activity could be explained, at least in 
part, by its adrenal leptin resistance.22 Interestingly, adrenal 
leptin resistance characterizing MSG rats could be restored 
after normalization of leptinemia due to adrenal enucleation 
(AE),21 thus indicating that regenerating adrenocortical cells 
that have not been exposed for a long period of time to high 
concentrations of the adipokine did recover the normal 
inhibitory tone of leptin on ACTH-stimulated glucocorticoid 
secretion.
In spite of the above, and based on the hypothesis that 
enhanced HPA axis activity could be a key factor for the 
development of the pseudo-obese phenotype in MSG- 
damaged rats, the aims of the present study were to: (a) 
characterize adipose tissue morphology and function, and 
peripheral insulin sensitivity, and (b) determine whether AE- 
induced correction of enhanced adrenocortical activity 
could be relevant for amelioration of some abnormalities 
characterizing pseudo-obese rats.
Materials and methods
Animals and treatment
Adult male (300-330 g body weight (BW)) and female (240- 
280 g BW) Sprague-Dawley rats were allowed to mate in 
colony cages in a light (lights on from 0700 to 1900 h)- and 
temperature (22°C)-controlled room. Rat chow and water 
were available ad libitum. Pregnant rats were transferred to 
individual cages. Beginning on day 2 after parturition, 
female newborns were injected i.p. with either 4mg/g BW 
MSG (Sigma Chemical Co., St Louis, MO, USA) dissolved in 
sterile 0.9% NaCl or 10% NaCl (litter-mate controls; CTR) 
once every 2 days up to day 10 of age.23 Rats were weaned at 
21 days of age; daily BW and food intake of rats were 
recorded up to the experimental day (120 days of age). MSG- 
injected animals were screened for effectiveness of treatment 
by decreased hypothalamic NPY mRNA expression and 
macroscopic observation of degeneration of the optic nerves 
at the time of killing. In each experiment, CTR and MSG 
female rats were members of the same litters; however, when 
accumulating experiments, each different experiment was 
performed with (CTR and MSG) animals from different 
litters. As MSG rats had an abnormal estrous cycle, the 
microscopic observations of their daily vaginal smears 
showing a constant diestrous stage, we used rats from 
CTR litters for experimentation after ascertaining by screen­
ing that they were at the diestrous stage of their estrous 
cycle.
Our Institutional Animal Care Committee approved 
all experimental designs. Animals were killed by decapita­
tion, according to the protocols for animal use, in agreement 
with NIH guidelines for care and use of experimental 
animals.
Experimental designs
Experiment 1. Intact (nonoperated) CTR and MSG animals 
(10-12 rats per group) were killed by decapitation (between 
0830 and 0915 h) in nonfasting condition. Trunk blood was 
collected into plastic tubes containing 0.2 ml EDTA (10% 
w/v) for further measurement of different metabolites in 
plasma samples (see below). Immediately after killing of 
rats, freshly dissected retroperitoneal (RP) fat pads were 
weighed and used for either histological or adipocyte 
function studies.
For histological studies of adipocytes, adipose (RP) tissues 
were fixed in Bouin's fluid and embedded in paraffin. 
Sections of 4 /nil were obtained, at different levels of the 
blocks, and stained with hematoxylin-eosin. Adipose tissue 
sections were incubated for 1 h at room temperature with the 
primary serum anti-leptin (rabbit polyclonal, Santa Cruz 
Biotechnology Inc., USA), diluted 1:200. Thoroughly washed 
sections were treated for 30 min with a ready-to-use EnVision 
reaction system (Dako, CA, USA). Diaminobenzidine was 
used as the peroxide-sensitive chromogen. The specificity of 
the primary antiserum was monitored by ability to block the 
immunocytochemical reaction by either pre-absorption of 
the antibody with an excess of leptin or replacement of the 
specific antibody by, similarly diluted, normal rabbit serum. 
Morphometric studies were performed as previously reported 
in detail.24 Briefly, measurements of adipocyte parameters 
were made with an image analysis system (Imaging Technol­
ogy, Optimas 5.2). Each field of immunostained cells in the 
reference area (RA; area scanned where adipocytes were 
scored) was measured for an average of 10 micrographs taken 
from two levels (e.g. a and b). These measurements were 
recorded and processed automatically, and the following 
parameters calculated afterwards: volume density (VD = Xa- 
dipocyte area/RA), cell density (CD = number of adipocytes/ 
RA) and cell size (CS; expressed in /mi2). Then, with the sum 
(J2) of the individual areas (A) of adipocytes, referred to as 
RA, we obtained VD, which indicates cell mass. The number 
of cells (CD) was calculated by dividing the immunostained 
area of the adipocyte population by the mean individual cell 
area. For this parameter, 100 adipocytes were recorded.
For studies on adipocyte function, RP fat pads were used 
for isolation of adipocytes as described previously.25 Briefly, 
preweighed fat pads (n = 2-3 rats per group per experiment) 
were slightly minced and placed in KREBS-MOPS medium 
(Sigma-Aldrich Co., St Louis, MO, USA) containing 1% BSA 
and 0.1% collagenase (Sigma-Aldrich, Type 1) in a ratio of 
3 ml of solution per gram of fat tissue. Tissues were gently 
shaken at 37°C for 50min in polypropylene flasks in a 95% 
air-5 % CO2 atmosphere inside a metabolic incubator. At the 
end of this period, cell suspensions were filtered through one 
layer of nylon cloth (100/nil), transferred to conical poly­
propylene tubes and centrifuged at lOOy for 20 min at room
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temperature. Cells were then washed three times with 
medium alone to eliminate the stromavascular fraction and 
collagenase. Adipocytes were then counted and diluted with 
DMEM (Sigma-Aldrich)-1% BSA medium, pH 7.4, to the 
necessary volume to obtain approximately 4 x 10s adipo­
cytes per 1.4 ml of medium. This volume was distributed into 
each 15 ml conical polypropylene tube containing 0.1ml of 
medium either alone (basal) or with different concentrations 
of insulin (Sigma-Aldrich; 0.2 and 5.0 nM).25 At least six tubes 
(replicates) per experimental condition were run in each 
experiment. Tubes were incubated by shaking at 37°C for 2h 
in a 95% air-5% CO2 atmosphere. At the end of incubation, 
tubes were centrifuged for 20 min at 100g; the infranatant 
was separated from adipocytes and kept frozen (-20°C) until 
measurement of medium leptin concentration.
Experiment 2. Effects of bilateral AE on peripheral insulin 
sensitivity - AE21 is a surgery carried out by the dorsal 
approach and under light ketamine anesthesia, exposing the 
adrenals and making a puncture in the capsule; thereafter, 
the parenchyma is extruded by squeezing the gland very 
gently with forceps and leaving the capsule intact. AE 
animals, once recovered, were maintained by drinking 
0.9% (w/v) NaCl solution up to day 4 after surgery. Thus, 
AE induces a transient decrease in adrenal glucocorticoid 
production that in turn triggers adrenal regeneration, a 
process which is normally complete 21 days after AE.21 Thus, 
on day 21 before experimentation, CTR and MSG were 
subjected to either sham surgery (performed by exposing the 
glands but without touching the glands or their pedicles; 
sham-CTR and sham-MSG groups) or AE (AE-CTR and AE- 
MSG groups). Metabolic responses to high glucose load were 
evaluated in groups of 24-h-fasting CTR and MSG rats 
subjected to either sham operation or AE (bearing an 
indwelling i.v. cannula, implanted 48 h before the experi­
ment). Animals (7/ 8-10 rats per group/condition) were
bled, on day 21 after surgery, before (sample time zero) and 
at several times (5, 15, 30, 60 and 90 min) after glucose (2g 
per kg BW) i.v. administration.26 Plasma samples, split into 
aliquots, were kept frozen (-20°C) until determination of 
glucose, insulin and leptin concentrations.
Experiment 3. Effects of bilateral AE on RP adipocyte function - 
On day 120 of age, different groups of rats (sham-CTR, sham- 
MSG, AE-CTR and AE-MSG; n = 2-3 rats per group/condition 
per experiment) were weighed and rapidly killed (between 
0830 and 0915 h, in nonfasting condition) by decapitation. 
Trunk blood, collected into plastic tubes containing 0.2 ml 
EDTA 10%, was immediately centrifuged for further deter­
mination of different metabolites in plasma samples (see 
below). Preweighed RP fat pads from different group/ 
condition were processed for isolation of adipocytes as 
described in Experiment 1. Then 4 x 10s adipocytes per 
1.4 ml of medium were incubated, as described above, with 
0.1 ml of medium alone (basal) or containing insulin (Sigma- 
Aldrich, 0.2 and 1.0 nM) or dexamethasone (DXM; Sigma- 
Aldrich; 25 and 50nM).27 At least six tubes (replicates) per 
experimental condition were run in each experiment. At the 
end of the incubations, tubes were processed as described 
above and the concentration of leptin released into the 
medium was then evaluated.
Metabolite determination
Plasma glucose concentrations were determined by an 
enzymatic-colorimetric assay from Weiner Lab. (Argentina). 
Circulating ACTH concentrations were measured by a 
previously validated immunoradiometric assay28 from our 
laboratory; the standard curve ranging between 15 and 
3000 pg/ml and intra- and interassay coefficients of variation 
(CVs), respectively, of 2-3 and 6-8%. Leptin circulating 
levels were determined by a specific radioimmunoassay (RIA) 
developed in our laboratory and validated for mouse and rat 
leptin against a commercial kit from Linco Res. Inc.;29 the 
standard curve ranged between 0.2 and 25 ng/ml, with intra- 
and interassay CVs of 5-8 and 10-12%, respectively. Insulin 
circulating levels were determined by a specific rat RIA 
previously developed in our laboratory;30 the standard curve 
ranged from 0.1 to 10 ng/ml, intra- and interassay CVs were 
3-7 and 8-11%, respectively. Finally, plasma free corticoster­
one (FB) concentrations were measured as earlier reported.31 
Briefly, a 50 /d steroid-stripped serum sample appropriately 
diluted in assay buffer was incubated overnight (4°C) with 
graded concentrations of cold B (200 /d) in the presence of 
3H-B (New England Nuclear; approximately lOOOOc.p.m. in 
50 /d of assay buffer); we separated bound from free hormone 
fractions by adding 0.1ml charcoal (1 g%)-dextran T 70 
(0.1 g%). Bound radioactivity was determined in a Tracor 
Analytic Scintillation System. Analysis of binding data for 
further determination of the concentration and affinity of 
corticosteroid-binding globulin (CBG) and circulating FB 
levels were carried out as reported previously.31
Data analysis
Data were expressed as the mean + s.e.m. Mean values were 
compared by ANOVA or ANOVA with repeated measures 
(when appropriate), followed by post-hoc comparisons with 
Fisher's test.32 Morphometric data were analyzed by the least 
significant difference test for multiple comparisons.32
Results
Body characteristics and circulating hormone levels in the MSG 
female rat
MSG rats have daily eaten, since weaned, a significantly 
lower amount of food than CTR litters (not shown). As 
previously found,22 1 20-day-old MSG female rats displayed a 
60% (approximately) reduction in hypothalamic NPY mRNA 
expression and optic nerve degeneration when examined 
immediately after the killing (not shown). Moreover, as
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shown in Figure 1, at age 120 days, animals have developed 
the classical phenotype of hyperadiposity and stunted 
growth; characteristics associated with a significantly 
(P<0.05 vs CTR rats) higher RP adipose tissue mass, despite 
significantly (P<0.05) lower BW than their normal counter­
parts (CTR) (Table 1).
Results from circulating concentrations of several hor­
mones determined in intact 120-day-old female CTR and 
MSG rats, at the trough time of day33 and in nonfasting 
condition, are included in Table 1. These data indicate that 
basal plasma ACTH concentrations were similar in both 
groups examined. However, MSG rats displayed significantly 
(PcO.OS) higher circulating levels of FB, insulin and leptin 
than CTR animals.
Histological, immunohistochemical and morphometric 
characteristics of adiposity in CTR and MSG-damaged rats 
Owing to the increased RP fat mass and leptinemia displayed 
by MSG-treated rats, we explored whether these character­
istics were associated with qualitative/quantitative modifica­
tions of the adipogénie process. Figure 2 shows 
representative fields of RP adipose tissue from intact CTR
Figure 1 Characteristic adult (120-day-old) hyperadipose phenotype of the 
MSG female rat (CTR: age-matched normal female rat).
Table 1 Basal circulating levels of several parameters, BW values and RP fat 
mass in nonoperated, CTR and MSG female rats at 120 days of age
Values are the mean + s.e.m., n = 10-12 rats per group. +P<0.05 vs CTR 
values.
Parameter CTR MSG
ACTH (pg/ml) 29.09 + 2.61 30.98 + 3.54
FB (ng/dl) 46.01 + 9.03 95.77 + 14.11 +
Leptin (ng/ml) 3.94 + 0.72 33.52 + 8.34+
Insulin (ng/ml) 0.61 +0.11 0.92 + 0.13+
BW (g) 223.4 + 7.48 174.6 + 10.8+
RP fat mass (g/IOOg BW) 1.85 + 0.41 4.01 +0.51 +
(panels a and c) and MSG (panels b and d) animals, either 
hematoxylin-eosin-stained (panels a and b) or specifically 
immunolabeled for leptin (panels c and d). The MSG- 
damaged rats presented large adipocytes that showed an 
ochre cytoplasmic rim labeled for leptin (Figure 2d).
Morphometric analyses of RP unilocular adipocytes in 
both experimental groups indicate that MSG rats displayed a 
significant (PcO.Ol) increase in cell VD (Figure 2e) vs CTR 
adipocytes, and consequently a significant (PcO.OOl) de­
crease in CD (Figure 2f). These morphometric characteristics
CTR MSG
Figure 2 Representative fields of RP adipose tissue from CTR (a, c) and MSG 
(b, d) rats. RP adipocytes were stained with hematoxylin-eosin (a, b) and 
immunolabeled for leptin (c, d); they all show the cytoplasmic rim of mature 
unilocular adipocytes. Micrographs were taken with an \ 20 objective. 
Morphometric analyses (e-g) of RP adipocytes (e-g) from CTR and MSG 
animals. VD: volume density, CD: cell density and CS: cell size. Values are the 
mean + s.e.m. (n = 6 rats per group). tP<0.01 vs the respective CTR values.
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were associated with a significant (PcO.OOl) increase in CS 
(Figure 2g).
Effect of neonatal MSG treatment on RP adipose tissue function 
in vitro
Figure 3 shows the results of leptin release into the medium 
by isolated RP adipocytes (from intact CTR and MSG rats) 
incubated in the absence (basal) or presence of several 
concentrations of insulin (0.2-S.0nM). Basal leptin release by 
MSG adipocytes was significantly (PcO.OS) greater than that 
spontaneously secreted by CTR cells. As depicted, CTR
Basal Insulin (nM)
Figure 3 Leptin release into the medium by isolated RP adipocytes from CTR 
and MSC rats (n 2-3 animals per experiment), incubated in vitro in the 
absence (basal) or presence of several concentrations of insulin (0.2-5.0nM). 
Values are the mean + s.e.m. (n 3 different experiments, 5-6 replicates per 
condition in each experiment). *P<0.05 vs MSC values in similar condition. 
*P<0.05 vs basal values in the respective cell group. **P<0.05 vs 0.2nM 
insulin values in the respective cell group.
adipocytes significantly (P<0.05 vs basal values) respond, 
in a concentration-related fashion, to all insulin concentra­
tions assayed. As depicted, whereas the two lower concen­
trations (0.2 and 0.5 nM) of insulin tested were equipotent 
for releasing leptin, 1 and 5 nM insulin were able to elicit 
higher responses (P<0.05) than that observed with 0.2 nM 
insulin. Conversely, adipocytes from MSG rats were signifi­
cantly (P<0.05) less sensitive to insulin stimulation, regard­
less of the insulin concentration used. As depicted, 1 nM or 
higher insulin concentration was needed to significantly 
(P<0.05) enhance leptin release over the respective baseline.
Effects ofAE on basal circulating hormone levels and BW 
characteristics
Table 2 shows the results of several parameters measured, in 
basal conditions, in CTR and MSG subjected to different 
surgeries. No differences were found in any of these 
parameters between intact (Table 1) and sham-operated rats 
from both groups (Table 2). However, while CTR rats 
displayed normal plasma ACTH levels on day 21 post-AE, 
AE-MSG showed significantly (P<0.05 vs AE-CTR values) 
higher circulating concentrations of ACTH. Table 2 also 
shows that AE in MSG rats was able to normalize circulating 
FB levels and, interestingly, insulin and leptin plasma 
concentrations. Finally, although group differences in BW 
values remained, we found a significant (P<0.05) decrease in 
RP fat pad mass in both groups of AE rats (Table 2).
Effect ofAE on metabolic responses to acute i.v. high glucose 
load
Figure 4 shows the circulating levels of several parameters in 
basal condition (time zero) and at different times after i.v. 
administration of glucose (2g/kg BW) in 24-h-fasting, CTR 
and MSG, rats either sham operated (panels a-c) or AE 
(panels d-f). Figure 4a shows glucose circulating levels, 
before and several times after high glucose load, in both 
sham-operated groups. As depicted in Figure 4a, despite 
similar basal levels, circulating glucose concentrations 
significantly (P<0.05) peaked, in a similar fashion, in both 
groups 5 min post-glucose administration; however, plasma 
glucose levels, at 15 and 30 min, were significantly (P<0.05) 
higher in sham-MSG than in sham-CTR rats. Sham-MSG rats
Table 2 Basal circulating levels of several parameters, BW values and RP fat mass in sham and AE, CTR and MSC female rats at 120 days of age
Parameter Sham-CTR Sham-MSC AE-CTR AE-MSG
ACTH (pg/ml) 27.88 + 3.13 35.88 + 9.75 36.77 ±7.59 69.79 + 9.96*
FB (ng/dl) 45.77 + 7.01 99.12 + 8.85* 55.08 + 5.14 65.02 + 7.09
Leptin (ng/ml) 4.13 + 1.09 31.97 + 4.41* 2.81 +0.75 4.38 + 1.99
Insulin (ng/ml) 0.63 + 0.13 0.98 + 0.16* 0.54 + 0.38 0.61 +0.22
BW (g) 228.8 + 5.1 211.8 + 7.9* 233.2 + 8.9 207.9 + 9.9*
RP fat mass (g/IOOg BW) 1.76 + 0.08 3.43 + 0.18* 1.18+0.14* 2.36 + 0.23*-*
Values are the mean + s.e.m.,, n = 10 rats per group/surgery. fP< 0.05 vs CTR values in similar condition. *P<0.05 vs sham-CTR values. *P<0.05 vs sham-MSC and
AE-CTR values.
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Figure 4 Effect of sham operation or AE on changes in circulating metabolite concentrations, before and at several times after i.v. high glucose load, in normal 
(CTR) and hyperadipose (MSG) rats. Values are the mean + s.e.m. (n = 7-9 rats per group/surgery). *P<0.05 vs MSG values in similar condition (ANOVA repeated 
measures).
displayed (Figure 4b) basal hyperinsulinemia (vs sham-CTR 
rats), and glucose load induced a statistically similar increase 
in insulin values in both groups, 5 and 15 min post-glucose; 
however, sham-MSG rats displayed higher insulinemia (vs 
sham-CTR values), 30 and 60 min post-glucose. Finally 
(Figure 4c), 15 min after i.v. high glucose load, circulating 
leptin levels (expressed in ng/ml/lOOg BW) were signifi­
cantly (P<0.05) enhanced (over time-zero values) in sham- 
CTR rats; thereafter, plasma leptin concentrations were back 
to baseline at 30 min post-glucose load. Although sham-MSG 
rats did also respond to high glucose administration by 
increasing (over the baseline) circulating leptin levels, this 
occurred in a significant (P<0.05) fashion later than in 
sham-CTR animals (30-90 min post-stimulus).
Interestingly, those significant differences found between 
sham-operated, CTR and MSG, rats were fully abrogated after 
AE of animals. In fact, the patterns of glucose (Figure 4d) and 
insulin (Figure 4e) levels, before and after high glucose load, 
were similar in both groups of AE rats examined. AE also was 
able to fully reverse hyperleptinemia in MSG rats (Figure 4f), 
and high glucose load did not modify circulating leptin 
levels throughout the period examined, regardless of the 
group.
Impact ofAE on adipocyte activity in vitro
Additional experimentation was performed to study the 
impact of transient correction of the enhanced circulating 
concentrations of hormones known to modify adipocyte 
function, for example, FB, insulin and leptin. For this 
purpose, a similar number of RP adipocytes from sham- 
operated and AE rats, from both groups, was incubated in the 
absence (basal) or presence of either insulin (0.2 and 1 nM) or 
DXM (25 and 50 nM), stimuli known to operate through 
different mechanisms. The results indicated that RP adipo­
cyte function (both basal and insulin-elicited leptin output) 
in sham-operated (Figure 5a) and intact (Figure 3) rats was 
essentially similar, regardless of neonatal treatment. In 
addition, while both DXM solutions tested were able to 
induce a significant (P<0.05 vs respective basal values)
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Basal Insulin (nM) DXM (nM)
that the decreased sensitivity of sham-MSG cells to these 
DXM concentrations could be related to their intrinsically 
higher spontaneous leptin output; thus, it should not be 
excluded that DXM concentrations >50nM could still 
induce higher leptin secretion. As found in experiments 
with adipocytes from intact MSG rats (Figure 3), adipocytes 
from sham-MSG spontaneously released more (P<0.05) 
leptin than adipocytes from sham-CTR rats, and these cells 
were sensitive for releasing leptin only after incubated with 
the highest concentration of both stimuli tested (Figure 5a). 
The pattern of leptin secretion by adipocytes from AE-CTR 
rats (Figure 5b) was similar to that developed by sham-CTR 
adipocytes (Figure 5a) after incubation in similar conditions. 
Interestingly, AE in MSG rats was able to significantly 
(P<0.05 vs sham-MSG basal values) reduce basal leptin 
secretion by isolated RP adipocytes (Figure 5b). In addition, 
AE in MSG rats enhanced RP adipocyte sensitivity. In fact, 
both concentrations of insulin and DXM tested significantly 
(P<0.05 vs the respective basal values) enhanced leptin 
release into the medium, in a fashion even more pronounced 
(P<0.05) than AE-CTR cells did (Figure 5b).
Basal Insulin (nM) DXM (nM)
Figure 5 Effect of AE on RP adipocytes from CTR and MSG rats (n = 2-3 
animals per experiment), responses to several concentrations of insulin or 
DXM. Values are the mean + s.e.m. (n = 3 different experiments, 5-6 
replicates per condition in each experiment). tP<0.05 vs MSG values in 
similar condition. *P<0.05 vs basal values in the respective cell group. 
**P<0.05 vs 0.2nM insulin values in the respective cell group.
increase in leptin secretion in sham-CTR cells (Figure 5a), 
conversely, only 50 nM DXM induced a significant (P<0.05 
vs the respective baseline values) increase in leptin release by 
sham-MSG adipocytes (Figure 5a). It should be mentioned
Discussion
Our study strongly supports glucocorticoid dependency in 
the development of several characteristics of this hypo- 
thalamo-damaged, pseudo-obese phenotype in rats. In fact, we 
have demonstrated that hyperleptinemia, hyperinsulinemia, 
peripheral insulin resistance and adiposity characteristics, 
mass and function, can be fully reversed by the transient 
correction of corticoadrenal hyperactivity (normalization of 
circulating FB levels due to AE) in the MSG female rat model. 
It should be stressed that the correction of insulin resistance 
in MSG rats subjected to AE appeared without significant 
changes in rat BW (Table 2), although AE-MSG rats remain 
lighter than their normal enucleated counterparts.
In previous studies from our laboratory, we found that AE 
is a very precise tool to demonstrate that enhanced 
corticoadrenal function is responsible for MSG-induced 
adrenocortical leptin resistance21 and hyperadiposity.30 
Thus, our previous and current studies strongly support that 
this nongenetic, pseudo-obese phenotype developed with 
enhanced adrenocortical activity. Other authors demon­
strated that adrenalectomy (ADX) abolished the ob/ob mouse 
phenotype.34 However, these results are predictable because 
of both a full lack of the orexigenic effect exerted by 
glucocorticoids35 and the increase in hypothalamic CRH- 
ergic activity, a potent anorectic signal,35 after ADX. The 
main difference between our and that study, beside models, 
is that 21-day AE-induced transient correction of circulating 
glucocorticoid did not modify food intake (data not shown), 
although body fatness and insulin sensitivity became normal 
in MSG rats. Conversely, spontaneous restoration of high 
glucocorticoid production (e.g. 35 days after AE) in MSG rats 
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resulted in augmented body fat mass,30 thus clearly suggest­
ing a direct glucocorticoid dependency in body fatness 
development, regardless of food intake.
Although we found no significant change in basal 
circulating levels of ACTH in intact MSG rats, this observa­
tion tallies with previous findings for adult male MSG rats.21 
Conversely, circulating FB concentrations were significantly 
higher in MSG than in CTR rats. Additionally, reduced 
corticosterone clearance rate9,10 and increased fasciculata to 
glomerolosa width ratio11 have been reported in MSG rats. 
Thus, these additional abnormalities could contribute to the 
high glucocorticoid levels characterizing this animal model.
Our study also shows morphological RP adipose tissue 
characteristics of the adult female MSG rat, such as enlarged 
adiposity and clearly enhanced adipogenic activity. It is 
accepted that the target white adipose tissue (e.g. RP fat) is 
characterized by the presence of adipocytes with a unique 
lipid inclusion (unilocular) and eccentric nucleus. Fat mass 
depot results from the balance between lipogenesis and 
lipolysis.36 While lipogenesis encompasses lipid synthesis, 
adipogenesis is a process consisting in the differentiation of 
pre-adipocyte to mature adipocyte. The development of 
target adipose tissue occurs rapidly after birth as a result of an 
increment in both adipocyte size and number.37 Even in 
adult life, the potential for generating new adipocytes 
persists, and differentiation and metabolism are regulated 
by a variety of endocrine and paracrine factors.38 In MSG 
rats, RP adipocytes displayed a significant increase in VD at 
the expense of an increase in CS, a parameter clearly 
supporting adipogenesis. Moreover, enlarged adipocyte size 
has been directly associated with hyperleptinemia.39 In 
addition, the fact that RP MSG adipocytes displayed in vitro 
insulin resistance could partly contribute to development of 
reduced lipolysis.40
AE is known to be a surgical approach that decreases (on 
days 2-S post-surgery) glucocorticoid production; as a result, 
enhanced hypothalamo-corticotrope activity develops be­
cause of the transient loss of glucocorticoid negative feed­
back.33 The fall in glucocorticoid production, 2 days 
post-AE,21 enhances ACTH secretion in plasma, thus allow­
ing the adrenal cortex to fully regenerate. This process, 
though completed 21 days post-AE in normal rats, is delayed 
up to 35 days in MSG animals.21 The transient decrease in 
circulating glucocorticoid levels after AE represents a dimin­
ished peripheral, glucocorticoid, adipogenic signal.41 It is 
also important to note that enhanced ACTH levels after AE 
will impact adipocytes inhibiting leptin secretion17,42 and 
probably adipogenesis (unpublished observation from our 
laboratory). Thus, these two signals contribute to AE- 
induced reduction in adipose tissue mass and leptin secre­
tion. Moreover, we found that among changes induced by 
AE, in this pseudo-obese phenotype, included the normal­
ization of insulinemia, leptinemia, peripheral insulin sensi­
tivity, and RP adipocyte function and morphometric 
characteristics (not shown). Therefore, the decrease in 
circulating levels of insulin, another adipogenic signal,43,44 
could also contribute to the changes observed in the AE-MSG 
female rat.
The development of hyperadiposity and insulin resistance 
in MSG-damaged rats has been described previously.14,45,46 
Although we previously described30 that, in male MSG rats, 
AE is able to reduce both enhanced body fatness and 
hyperleptinemia, to our knowledge, these data are the first 
showing that transient correction of enhanced adrenocor­
tical function, in the adult AE-MSG female rat, resulted in: 
(a) full reversion of peripheral insulin resistance and (b) 
normalization of, in vivo and in vitro, adipocyte function. It 
has been proposed that the stimulatory effect of insulin on 
adipocyte glucose transport is diminished in adult MSG 
rats,46 an effect probably dependent on both low adipocyte 
insulin binding, unrelated to TNFa overproduction,47 and 
reduced GLUT4 protein content. However, other authors 
also found that cells from several insulin-sensitive tissues of 
MSG rats display increased protein insulin receptor-tyrosine 
phosphatase IB interaction and impaired downstream 
insulin signaling.48 The inhibitory effect of glucocorticoid 
on insulin action in rat adipocytes is a well-recognized 
mechanism.49,50 However, these alterations have been attrib­
uted to alterations in insulin-mediated glucose transport,49,51 
not to changes in adipocyte insulin binding.51 Also, high 
leptin circulating levels are known to alter insulin action.52,53 
For instance, human hepatic cells exposed in vitro to leptin, at 
concentrations comparable with those present in obese 
individuals, display attenuation of several insulin-induced 
activities. Two of these are tyrosine phosphorylation of the 
insulin receptor substrate-1 (IRS-1) and gluconeogenesis.53 
Therefore, the deleterious effect of an excess of glucocorticoid, 
due to enhanced production and/or reduced urinary excre­
tion,9,10,54 on insulin sensitivity could be further affected by 
the hyperleptinemia characterizing the MSG animal model.
In summary, our study strongly supports that AE-induced 
transient correction of increased adrenal cortex activity in 
pseudo-obese MSG female rats: (a) decreases leptinemia and 
insulinemia and (b) restores normal peripheral insulin 
sensitivity and adipocyte function. Thus, enhanced adreno­
cortical activity seems to be the key factor in the develop­
ment of this phenotype of hypothalamic hyper-adiposity 
and, what is important in a therapeutic perspective, the 
correction of adrenocortical hyper-function reversed these 
abnormalities.
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